Larotrectinib Intermediates CAS:33884-43-4
Product Description
2-(2-bromoethyl)-1,3-dioxane ,CAS No.:33884-43-4,It is an intermediate of Larotrectinib.Loxo 101 can treat locally advanced or metastatic solid tumors with NTPK gene fusion in adults and children.
Jinan Guoding Pharmaceutical Co., Ltd. is a high-tech company specialized in R & D, production, operation and sales of pharmaceutical intermediates and API products. We provides services such as technology development, technology transfer technical services. and also provides high quality products, based on the principle of "quality first, integrity essential, customer service, and technological innovation", with innovation driven as the core, quality management as the guarantee, the company is aggressive and innovative, and is committed to providing customers with high-quality products and professional services.
Product Name:2-(2-bromoethyl)-1,3-dioxane
CAS:33884-43-4
Purity:98.0%
Molecular Formula:C6H11BrO2
Mol Weight:195.06
Packing:Export worthy packing
MSDS:Avaliable on request
Other Intermediates of Our company:
1、Larotrectinib Intermediates
2、Entrectinib Intermediates
3、Repotrectinib Intermediates
4、Brigatinib Intermediates
5、Ibrutinib Intermediates
6、Praprofen Intermediates
7、Alectinib Intermediates
8、Amenmevir Interemdiates
9、Pyrazolopyrimidine Intermediates
10、Active Pharmaceutical Ingredient
Product Categories : Larotrectinib Intermediates